Fidelity Investments
TERN

Fidelity Investments’s Terns Pharmaceuticals TERN Stock Holding History

Fidelity Investments’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6M Sell
295,622
-731,241
-71% -$30M ﹤0.01% 1873
2025
Q4 		$41.5M Buy
1,026,863
+966,513
+1,602% +$22.3M ﹤0.01% 1510
2025
Q3 		$453K Buy
60,350
+1,401
+2% +$8.95K ﹤0.01% 3065
2025
Q2 		$220K Buy
58,949
+57,587
+4,228% +$180K ﹤0.01% 3273
2025
Q1 		$3.76K Sell
1,362
-112,559
-99% -$460K ﹤0.01% 4774
2024
Q4 		$631K Sell
113,921
-1,058,603
-90% -$7.17M ﹤0.01% 2833
2024
Q3 		$9.78M Sell
1,172,524
-1,594,572
-58% -$13.1M ﹤0.01% 1929
2024
Q2 		$18.8M Buy
2,767,096
+4,970
+0.2% +$30.1K ﹤0.01% 1676
2024
Q1 		$18.1M Sell
2,762,126
-228,276
-8% -$1.49M ﹤0.01% 1693
2023
Q4 		$19.4M Sell
2,990,402
-2,127,648
-42% -$11.2M ﹤0.01% 1637
2023
Q3 		$25.7M Sell
5,118,050
-1,932,296
-27% -$12.3M ﹤0.01% 1489
2023
Q2 		$61.7M Sell
7,050,346
-592,412
-8% -$6.9M 0.01% 1191
2023
Q1 		$90.5M Buy
7,642,758
+264,117
+4% +$2.52M 0.01% 1021
2022
Q4 		$75.1M Buy
7,378,641
+7,277,002
+7,160% +$48.4M 0.01% 1085
2022
Q3 		$599K Sell
101,639
-36
-0% -$134 ﹤0.01% 2740
2022
Q2 		$252K Sell
101,675
-2,219,783
-96% -$4.43M ﹤0.01% 3069
2022
Q1 		$6.89M Sell
2,321,458
-479,527
-17% -$2.05M ﹤0.01% 2262
2021
Q4 		$19.8M Sell
2,800,985
-132,177
-5% -$1.1M ﹤0.01% 1830
2021
Q3 		$30.6M Sell
2,933,162
-89,395
-3% -$927K ﹤0.01% 1642
2021
Q2 		$37.1M Buy
3,022,557
+134,819
+5% +$2.3M ﹤0.01% 1570
2021
Q1 		$63.5M Buy
+2,887,738
New +$63.3M 0.01% 1284

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity Investments's TERN Position: Q1 2026 in Review

Fidelity Investments reduced its Terns Pharmaceuticals (TERN) stake by 71% in Q1 2026, selling an estimated $30M and leaving 295,622 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

Fidelity Investments first reported a position in TERN in Q1 2021 and has held it in 21 quarters since. The position peaked at $90.5M in Q1 2023. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Fidelity Investments held 295,622 shares of Terns Pharmaceuticals worth $15.6M as of Q1 2026.
  • Fidelity Investments sold 731,241 Terns Pharmaceuticals shares in Q1 2026, an estimated $30M.
  • Terns Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1873 holding.
  • Fidelity Investments first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Terns Pharmaceuticals position peaked at $90.5M in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.